{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:23:57Z","timestamp":1783700637513,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.virol.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T21:48:24Z","timestamp":1686520104000},"page":"82-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus"],"prefix":"10.1016","volume":"585","author":[{"given":"Mrunal","family":"Gosavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Kulkarni-Munje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad P.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2023.06.001_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/vbz.2014.1681","article-title":"Therapeutics and vaccines against chikungunya virus","volume":"15","author":"Ahola","year":"2015","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.virol.2023.06.001_bib2","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1016\/j.vaccine.2010.10.007","article-title":"The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes","volume":"28","author":"Budimir","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.06.001_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030898","article-title":"Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity","volume":"7","author":"Budimir","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.06.001_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0264-410X(93)90197-6","article-title":"Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus","volume":"11","author":"Budowsky","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.1401833","article-title":"CD8+ T cells control Ross river virus infection in musculoskeletal tissues of infected mice","volume":"194","author":"Burrack","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2023.06.001_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2023.06.001_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4161\/hv.7.8.16274","article-title":"Targeting skin layers for vaccination transcutaneous and intradermal vaccination","volume":"7","author":"Combadiere","year":"2011","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.virol.2023.06.001_bib8","first-page":"811","article-title":"Transcutaneous and intradermal vaccination","volume":"7","author":"Combadiere","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2334-10-31","article-title":"Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness","volume":"10","author":"de Andrade","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virol.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0264-410X(98)80006-6","article-title":"Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children","volume":"16","author":"Egemen","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.06.001_bib12","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1093\/infdis\/jiw271","article-title":"Development of vaccines for chikungunya fever","volume":"214","author":"Erasmus","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2023.06.001_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.virs.2022.01.032","article-title":"An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses","volume":"37","author":"Ge","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2023.06.001_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000138","article-title":"Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling","volume":"4","author":"Geeraedts","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2023.06.001_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-2659.2008.00038.x","article-title":"Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs","volume":"2","author":"Geeraedts","year":"2008","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.virol.2023.06.001_bib16","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1016\/j.vaccine.2022.07.018","article-title":"Evaluation of monophosphoryl lipid A as an adjuvanted for inactivated chikungunya virus","volume":"40","author":"Gosavi","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.06.001_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/501756","article-title":"Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers","volume":"21","author":"Henderson","year":"2000","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.virol.2023.06.001_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.virol.2023.06.001_bib19","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.4049\/jimmunol.178.11.6715","article-title":"Cutting edge: TLR2 directly triggers Th1 effector functions","volume":"178","author":"Imanishi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2023.06.001_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041529","article-title":"Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine","volume":"7","author":"Jackson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.06.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-69614-7","article-title":"Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes","volume":"10","author":"Janovec","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2023.06.001_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.06.001_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2023.06.001_bib24","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"Kumar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.06.001_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2013.11.013","article-title":"Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine","volume":"174","author":"Patil","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.virol.2023.06.001_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-020-03933-5","article-title":"Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India","author":"Patil","year":"2020","journal-title":"Eur J Microbiol Infect Dis"},{"key":"10.1016\/j.virol.2023.06.001_bib27","series-title":"Cutting Edge: New Chimeric NOD2\/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity","author":"Pavot","year":"2017"},{"key":"10.1016\/j.virol.2023.06.001_bib28","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1128\/JVI.01849-09","article-title":"Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization","volume":"84","author":"Quan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.06.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1007811","article-title":"Innate immune memory through TLR2 and NOD2 contributes to the control of leptospira interrogans infection","volume":"15","author":"Santecchia","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2023.06.001_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","article-title":"Biology and pathogenesis of chikungunya virus","volume":"8","author":"Schwartz","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2023.06.001_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.vaccine.2011.11.054","article-title":"Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands","volume":"30","author":"Shafique","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.06.001_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061287","article-title":"Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses","volume":"8","author":"Shafique","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.06.001_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061287","article-title":"Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses","volume":"8","author":"Shafique","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.06.001_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2009.06.027","article-title":"Systemic involvements and fatalities during Chikungunya epidemic in India","volume":"46","author":"Tandale","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virol.2023.06.001_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0974-777X.83526","article-title":"Clinical profile of chikungunya patients during the epidemic of 2007 in Kerala, India","volume":"3","author":"Vijayakumar","year":"2011","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.virol.2023.06.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003764","article-title":"High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines","volume":"9","author":"Yoon","year":"2015","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T15:18:18Z","timestamp":1722611898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223001253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":36,"alternative-id":["S0042682223001253"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.06.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}